"Engaging Paracelsus, Inc. has been an extremely efficient route for Neuralstem’s drug development effort. Since 2009 starting from just proof-of-concept animal data to 2010 successful..."
Neuralstem
Karl Johe, PhD

Expertise

Toxicology / Grace M. Furman, PhD DABT

Veterinary Pathology / Gerald J. Kolaja, DVM, PhD, DACVP

Pharmacology / Fred R. Kohn, PhD

Pharmacokinetics / Fred R. Kohn, PhD

Regulatory Affairs / Raymond C. Lamy, MS